Verseon (VSN.LN) Priced

Biotech targeting oral anticoagulants, diabetic retinopathy and solid tumors.

Health Care - Biotechnology

IPO Performance
Latest Trade $1.55 0.00 (0.0%)
First Day Return -30.1%
Return from IPO -49.5%
 
Verseon IPO News more
  • .
IPO Data
IPO File Date 05/01/2015
Offer Price $3.07
Price Range $3.07 - $3.07
Offer Shares (mm) 32.6
Deal Size ($mm) 100
 
IPO Data
IPO Date 05/01/2015
Offer Price $3.07
Price Range $3.07 - $3.07
Offer Shares (mm) 32.6
Deal Size ($mm) $100
 
Underwriters
more
Business Overview
Biotech targeting oral anticoagulants, diabetic retinopathy and solid tumors.
Biotech targeting oral anticoagulants, diabetic retinopathy and solid tumors.
more
Company Data
Headquarters Fremont,
Founded
Employees n/a
Website
 

Performance vs. IPO Index (IPOUSA)